{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:45:13Z","timestamp":1789195513091,"version":"build-2803163510"},"reference-count":139,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cholangiopathies are defined as focal or extensive damage of the bile ducts. According to the pathogenetic mechanism, it may be immune-mediated or due to genetic, infectious, toxic, vascular, and obstructive causes. Their chronic evolution is characterized by inflammation, obstruction of bile flow, cholangiocyte proliferation, and progression toward fibrosis and cirrhosis. Immune-mediated cholangiopathies comprise primary sclerosing cholangitis (PSC), autoimmune cholangitis and IgG4-associated cholangitis in adults and biliary atresia (BA), neonatal sclerosing cholangitis (NSC) in children. The main purpose of this narrative review was to highlight the similarities and differences among immune-mediated cholangiopathies, especially those frequent in children in which cholangiocyte senescence plays a key role (BA, NSC, and PSC). These three entities have many similarities in terms of clinical and histopathological manifestations, and the distinction between them can be hard to achieve. In BA, bile duct destruction occurs due to aggression of the biliary cells due to viral infections or toxins during the intrauterine period or immediately after birth. The consequence is the activation of the immune system leading to severe inflammation and fibrosis of the extrahepatic biliary tract, lumen stenosis, and impairment of the biliary flow. PSC is characterized by inflammation and fibrosis of intra- and extrahepatic bile ducts, leading to secondary biliary cirrhosis. It is a multifactorial disease that occurs because of genetic predisposition [human leukocyte antigen (HLA) and non-HLA haplotypes], autoimmunity (cellular immune response, autoantibodies, association with inflammatory bowel disease), environmental factors (infections or toxic bile), and host factors (intestinal microbiota). NSC seems to be a distinct subgroup of childhood PSC that appears due to the interaction between genetic predisposition (HLA B8 and DR3) and the disruption of the immune system, validated by elevated IgG levels or specific antibodies [antinuclear antibody (ANA), anti-smooth muscle antibody (ASMA)]. Currently, the exact mechanism of immune cholangiopathy is not fully understood, and further data are required to identify individuals at high risk of developing these conditions. A better understanding of the immune mechanisms and pathophysiology of BA, NSC, and PSC will open new perspectives for future treatments and better methods of preventing severe evolution.<\/jats:p>","DOI":"10.3389\/fimmu.2023.1206025","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T13:11:18Z","timestamp":1697807478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune-mediated cholangiopathies in children: the need to better understand the pathophysiology for finding the future possible treatment targets"],"prefix":"10.3389","volume":"14","author":[{"given":"Alina","family":"Grama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Mititelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"S\u00eerbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Ben\u0163a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tudor Lucian","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.08.024","article-title":"Cholangiopathies - Towards a molecular understanding","volume":"35","author":"Tam","year":"2018","journal-title":"EBioMedicine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00909-9","article-title":"Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target","volume":"44","author":"Trussoni","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/950713","article-title":"Cholangiopathy: genetics, mechanism, and pathology","volume":"2012","author":"Nakanuma","year":"2011","journal-title":"Int J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001981","article-title":"The relationship of cholangiocarcinoma with human immunodeficiency virus cholangiopathy and cytomegalovirus infection","volume":"7","author":"Yavuz","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.510300138","article-title":"Liver and bile duct pathology followingCryptosporidium parvuminfection of immunodeficient mice","volume":"30","author":"Stephens","year":"1999","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000501405","article-title":"Secondary sclerosing cholangitis in critically ill patients: an underdiagnosed entity","volume":"27","author":"Martins","year":"2020","journal-title":"GE Port J Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318204e658","article-title":"Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis","volume":"253","author":"Jay","year":"2011","journal-title":"Ann Surg"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.02.007","article-title":"Intravenous ketamine and progressive cholangiopathy in COVID-19 patients","volume":"74","year":"2021","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J Immunol Baltim Md 1950"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s1499-3872(14)60001-1","article-title":"Graft cholangiopathy: etiology, diagnosis, and therapeutic strategies","volume":"13","author":"Luo","year":"2014","journal-title":"Hepatobil Pancreat Dis Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00117-019-0513-x","article-title":"Immune-mediated cholangiopathies: Diagnostic and therapeutic challenges","volume":"59","author":"Herta","year":"2019","journal-title":"Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.40","article-title":"Elevated serum igG4 levels in diagnosis, treatment response, organ involvement, and relapse in a prospective IgG4-related disease UK cohort","volume":"111","author":"Culver","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"B13","first-page":"1","article-title":"Primary biliary cirrhosis","volume":"61","author":"Dauphinee","year":"1949","journal-title":"Can Med Assoc J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","article-title":"Current understanding of primary biliary cholangitis","volume":"27","author":"Tanaka","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.37136","article-title":"Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatol Baltim Md"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1080\/136518202760378489","article-title":"The Brisbane 2000 terminology of liver anatomy and resections","volume":"2","author":"Pang","year":"2000","journal-title":"HPB"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2008.07.001","article-title":"Biliary anatomy and embryology","volume":"88","author":"Vakili","year":"2008","journal-title":"Surg Clin North Am"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.803098","article-title":"Biliary epithelial senescence in liver disease: there will be SASP","volume":"8","author":"Meadows","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313173","article-title":"Mechanisms and regulation of cellular senescence","volume":"22","author":"Roger","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MPG.0b013e3181633562","article-title":"Biliary atresia: Swiss national study, 1994-2004","volume":"46","author":"Wildhaber","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103689","article-title":"Biliary Atresia - emerging diagnostic and therapy opportunities","volume":"74","author":"Lendahl","year":"2021","journal-title":"EBioMedicine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040999","article-title":"Biliary atresia in 2021: epidemiology, screening and public policy","volume":"11","author":"Schreiber","year":"2022","journal-title":"J Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/2193-1801-2-42","article-title":"Lack of HLA predominance and HLA shared epitopes in biliary Atresia","volume":"2","author":"Mack","year":"2013","journal-title":"SpringerPlus"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000371694","article-title":"Genetic contributors and modifiers of biliary atresia","volume":"33","author":"Mezina","year":"2015","journal-title":"Dig Dis Basel Switz"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-4-14","article-title":"Maternal microchimerism in the livers of patients with Biliary atresia","volume":"4","author":"Suskind","year":"2004","journal-title":"BMC Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4161\/chim.28576","article-title":"Maternal microchimerism in biliary atresia","volume":"5","author":"Muraji","year":"2014","journal-title":"Chimeris"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26512","article-title":"Extrahepatic anomalies in infants with biliary atresia: Results of a Large prospective North American multicenter study","volume":"58","author":"Schwarz","year":"2013","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"21815","DOI":"10.1038\/s41598-021-01148-y","article-title":"Novel findings from family-based exome sequencing for children with biliary atresia","volume":"11","author":"Tran","year":"2021","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147838","article-title":"Biliary atresia animal models: is the needle in a haystack","volume":"23","author":"Pal","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.74","article-title":"Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes","volume":"12","author":"Asai","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.09","article-title":"Basic liver immunology","volume":"13","author":"Gao","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI38879","article-title":"Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia","volume":"119","author":"Shivakumar","year":"2009","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00329","article-title":"Innate immunity and pathogenesis of biliary atresia","volume":"11","author":"Ortiz-Perez","year":"2020","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.1.3.375","article-title":"Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies","volume":"1","author":"Zola","year":"2001","journal-title":"Expert Opin Biol Ther"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810705","article-title":"The role of vitamin D and vitamin D binding protein in chronic liver diseases","volume":"23","author":"Pop","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4254\/wjh.v15.i1.52","article-title":"Liver immunity, autoimmunity, and inborn errors of immunity","volume":"15","author":"Parlar","year":"2023","journal-title":"World J Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4103\/2249-4863.201154","article-title":"Neonatal cholestasis due to primary sclerosing cholangitis","volume":"5","author":"Shetty","year":"2016","journal-title":"J Fam Med Prim Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/jmedgenet-2018-105625","article-title":"Kabuki syndrome: international consensus diagnostic criteria","volume":"56","author":"Adam","year":"2019","journal-title":"J Med Genet"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2013.06.013","article-title":"Liver abnormalities in bowel diseases","volume":"27","author":"Kummen","year":"2013","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200003000-00024","article-title":"Neonatal sclerosing cholangitis associated with autoimmune phenomena","volume":"30","author":"Bar Meir","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/MOG.0000000000000509","article-title":"Genetics in biliary atresia","volume":"35","author":"Girard","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32834c7ae4","article-title":"Rotavirus and biliary atresia: can causation be proven","volume":"28","author":"Hertel","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1053\/j.sempedsurg.2012.05.003","article-title":"Biliary atresia: cellular dynamics and immune dysregulation","volume":"21","author":"Feldman","year":"2012","journal-title":"Semin Pediatr Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0041-1739236","article-title":"Detection of cytomegalovirus infection in infants with biliary atresia: A meta-analysis","volume":"12","author":"Mohamed","year":"2022","journal-title":"Avicenna J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28363","article-title":"Toxic bile and sclerosing cholangitis: Is there a role for pharmacological interruption of the bile acid enterohepatic circulation","volume":"63","author":"Dawson","year":"2016","journal-title":"Hepatology"},{"key":"B51","unstructured":"Primary sclerosing cholangitis RawlaP SamantH StatPearls PublishingStatPearls2023"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0467-7","article-title":"The synthetic toxin biliatresone causes biliary atresia in mice","volume":"100","author":"Yang","year":"2020","journal-title":"Lab Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.022","article-title":"Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: A tight junction disease","volume":"127","author":"Hadj-Rabia","year":"2004","journal-title":"Gastroenterology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120019","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr Physiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.11.4390.4390","article-title":"Two-way cell traffic between mother and fetus: biologic and clinical implications","volume":"88","author":"Lo","year":"1996","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030825","article-title":"Tight junction proteins and the biology of hepatobiliary disease","volume":"21","author":"Roehlen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","author":"Aron","year":"2009","journal-title":"Semin Immunopathol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e0267363","DOI":"10.1371\/journal.pone.0267363","article-title":"Systemic cytokine profiles in biliary atresia","volume":"17","author":"Udomsinprasert","year":"2022","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80417-5","article-title":"Preferential V\u03b23 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis","volume":"26","author":"Bromm\u00e9","year":"1997","journal-title":"J Hepatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12103","article-title":"Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia","volume":"173","author":"Okamura","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: a target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0603272","article-title":"The main function of IL-2 is to promote the development of T regulatory cells","volume":"74","author":"Malek","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9089068","article-title":"Preoperative serum IL-12p40 is a potential predictor of kasai portoenterostomy outcome in infants with biliary atresia","volume":"2017","author":"Goda","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"B65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jhbp.816","article-title":"Clinical practice guidelines for biliary atresia in Japan: A secondary publication of the abbreviated version translated into English","volume":"28","author":"Ando","year":"2021","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1094895","article-title":"Neonatal sclerosing cholangitis with novel mutations in DCDC2 (doublecortin domain-containing protein 2) in Chinese children","volume":"11","author":"Wei","year":"2023","journal-title":"Front Pediatr"},{"key":"B67","first-page":"293","article-title":"Primary sclerosing cholangitis, part 1: epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04680514","article-title":"How the innate immune system senses trouble and causes trouble","volume":"10","author":"Hato","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/373878","article-title":"Biliary innate immunity: function and modulation","volume":"2010","author":"Harada","year":"2010","journal-title":"Mediators Inflammation"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-6-14","article-title":"Loss of interleukin-12 modifies the pro-inflammatory response but does not prevent duct obstruction in experimental biliary atresia","volume":"6","author":"Mohanty","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"B71","article-title":"Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis","volume":"32","author":"El-Faramawy","year":"2011","journal-title":"Trop Gastroenterol Off J Dig Dis Found"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.11.004","article-title":"Multiple roles of alpha-smooth muscle actin in mechanotransduction","volume":"312","author":"Wang","year":"2006","journal-title":"Exp Cell Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/pr.2013.170","article-title":"Reovirus type-2-triggered autoimmune cholangitis in extrahepatic bile ducts of weanling DBA\/1J mice","volume":"75","author":"Nakashima","year":"2014","journal-title":"Pediatr Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3109\/08830185.2010.529976","article-title":"Pathogen recognition by the innate immune system","volume":"30","author":"Kumar","year":"2011","journal-title":"Int Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.017","article-title":"Adaptive immunity","volume":"125","author":"Bonilla","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12399","article-title":"Human T helper type 1 dichotomy: origin, phenotype and biological activities","volume":"144","author":"Annunziato","year":"2015","journal-title":"Immunology"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179784","article-title":"An update on the effects of vitamin D on the immune system and autoimmune diseases","volume":"23","author":"S\u00eerbe","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3468(00)90211-2","article-title":"Elevation of serum interleukin-18 levels and activation of kupffer cells in biliary atresia","volume":"35","author":"Urushihara","year":"2000","journal-title":"J Pediatr Surg"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2006.11.002","article-title":"IL-12p40: an inherently agonistic cytokine","volume":"28","author":"Cooper","year":"2007","journal-title":"Trends Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00744-5","article-title":"CD8+ T cell exhaustion","volume":"41","author":"Kurachi","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1007\/BF02591635","article-title":"Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease","volume":"21","author":"Romagnani","year":"1992","journal-title":"Int J Clin Lab Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","article-title":"Biliary atresia is associated with CD4+ Th1 cell\u2013mediated portal tract inflammation","volume":"56","author":"Mack","year":"2004","journal-title":"Pediatr Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12900","article-title":"Interleukin-8: A critical chemokine in biliary atresia","volume":"30","author":"Dong","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev.cb.07.110191.002403","article-title":"T-cell effector functions: mechanisms for delivery of cytotoxicity and help","volume":"7","author":"Podack","year":"1991","journal-title":"Annu Rev Cell Biol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4103\/jomfp.JOMFP_85_17","article-title":"Microchimerism: A new concept","volume":"23","author":"Shrivastava","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00588","article-title":"Mechanisms of fetal T cell tolerance and immune regulation","volume":"11","author":"Rackaityte","year":"2020","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.10.005","article-title":"Selective organ-specific inflammation in offspring harbouring microchimerism from strongly alloreactive mothers","volume":"50","author":"Leveque","year":"2014","journal-title":"J Autoimmunity"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1007927","article-title":"Circulating maternal chimeric cells have an impact on the outcome of biliary atresia","volume":"10","author":"Masuya","year":"2022","journal-title":"Front Pediatr"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2009.02.005","article-title":"Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection","volume":"23","author":"Murata","year":"2009","journal-title":"Transplant Rev Orlando Fla"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-014-3553-3","article-title":"Positive C4d staining of the portal vein endothelium in the liver of patients with biliary atresia: a role of humoral immunity in ongoing liver fibrosis","volume":"30","author":"Fujisawa","year":"2014","journal-title":"Pediatr Surg Int"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2018.00046","article-title":"Evidence for viral induction of biliary atresia: A review","volume":"6","author":"Averbukh","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"FSO466","DOI":"10.2144\/fsoa-2019-0153","article-title":"Biliary atresia: pathology, etiology and pathogenesis","volume":"6","author":"Vij","year":"2020","journal-title":"Future Sci OA"},{"key":"B93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.epsc.2018.02.002","article-title":"Cytomegalovirus-associated biliary atresia","volume":"35","author":"Kodo","year":"2018","journal-title":"J Pediatr Surg Case Rep"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.710450","article-title":"Prognosis of biliary atresia associated with cytomegalovirus: A meta-analysis","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Pediatr"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30907","article-title":"Rotavirus reassortant\u2013induced murine model of liver fibrosis parallels human biliary atresia","volume":"71","author":"Mohanty","year":"2020","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2011.05.015","article-title":"Osteopontin upregulation in rotavirus-induced murine biliary atresia requires replicating virus but is not necessary for development of biliary atresia","volume":"417","author":"Hertel","year":"2011","journal-title":"Virology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270603","article-title":"Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts","volume":"27","author":"Tyler","year":"1998","journal-title":"Hepatology"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-985068","article-title":"The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease","volume":"27","author":"Mack","year":"2007","journal-title":"Semin Liver Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/icb.2008.37","article-title":"The immunobiology of cholangiocytes","volume":"86","author":"Chen","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","article-title":"Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110413","article-title":"Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells","volume":"129","author":"Chen","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e0105","DOI":"10.1097\/HC9.0000000000000105","article-title":"Liver organoids: established tools for disease modeling and drug development","volume":"7","author":"Sun","year":"2023","journal-title":"Hepatol Commun"},{"key":"B105","doi-asserted-by":"crossref","DOI":"10.1002\/j.1536-4801.2006.tb01758.x","article-title":"NEONATAL SCLEROSING CHOLANGITIS: KINGS COLLEGE HOSPITAL EXPERIENCE","volume":"42","author":"Charlesworth","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B106","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0377-1237(07)80085-2","article-title":"Sleisenger and Fordtran\u2019s Gastrointestinal and Liver Disease: pathophysiology, diagnosis, management","volume":"63","author":"Pithawa","year":"2007","journal-title":"Med J Armed Forces India"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J Gastroenterol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3109\/00365529008999209","article-title":"Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis","volume":"25","author":"Broom\u00e9","year":"1990","journal-title":"Scand J Gastroenterol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409794102","article-title":"Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury","volume":"102","author":"Stedman","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0209","article-title":"Anti-neutrophil antibodies in primary sclerosing cholangitis","volume":"15","author":"Terjung","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2004.09.003","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"4","author":"Aoki","year":"2005","journal-title":"Autoimmun Rev"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16153","article-title":"Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis","volume":"53","author":"Wunsch","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.162495","article-title":"Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn\u2019s disease","volume":"58","author":"Roggenbuck","year":"2009","journal-title":"Gut"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1021\/pr060665l","article-title":"Tumor necrosis factor-\u03b1- and interleukin-1-induced cellular responses:\u2009 Coupling proteomic and genomic information","volume":"6","author":"Ott","year":"2007","journal-title":"J Proteome Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"B118","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/critrevimmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25516","article-title":"Proinflammatory cytokines inhibit secretion in rat bile duct epithelium","volume":"121","author":"Spirl\u00ec","year":"2001","journal-title":"Gastroenterology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12711","article-title":"TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: Relationship with clinical characteristics","volume":"30","author":"Matsushita","year":"2015","journal-title":"J Gastroenterol Hepato"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nature23015","article-title":"Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration","volume":"547","author":"Raven","year":"2017","journal-title":"Nature"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.08.020","article-title":"Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma","volume":"1864","author":"Chung","year":"2018","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.livres.2017.05.002","article-title":"Cellular crosstalk during cholestatic liver injury","volume":"1","author":"J","year":"2017","journal-title":"Liver Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/mp.51.4.191","article-title":"The normal structure and function of CD44 and its role in neoplasia","volume":"51","author":"Sneath","year":"1998","journal-title":"Mol Pathol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5A1015-469R","article-title":"CD4+ T cells from patients with primary sclerosing cholangitis exhibit reduced apoptosis and down-regulation of proapoptotic Bim in peripheral blood","volume":"101","author":"Schoknecht","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy170","article-title":"High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis","volume":"13","author":"Lampinen","year":"2019","journal-title":"J Crohns Colitis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2511-y","article-title":"Circulating CD4+CD25+ Regulatory T cells in the pathobiology of ulcerative colitis and concurrent primary sclerosing cholangitis","volume":"58","author":"Kekilli","year":"2013","journal-title":"Dig Dis Sci"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/s0966-842x(03)00006-4","article-title":"Mimicking the way to autoimmunity: an evolving theory of sequence and structural homology","volume":"11","author":"Kohm","year":"2003","journal-title":"Trends Microbiol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/MOG.0b013e328325aa10","article-title":"Inflammation and biliary tract injury","volume":"25","author":"Lu","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24757","article-title":"Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis","volume":"55","author":"Takahashi","year":"2012","journal-title":"Hepatology"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136975","article-title":"The role of microbiota in primary sclerosing cholangitis and related biliary Malignancies","volume":"22","author":"\u00d6zdirik","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01851.x","article-title":"Occult hepatitis B virus infection in patients with autoimmune liver diseases","volume":"29","author":"Georgiadou","year":"2009","journal-title":"Liver Int"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1159\/000084605","article-title":"Primary sclerosing cholangitis and hepatitis C virus infection","volume":"48","author":"Kim","year":"2005","journal-title":"Intervirology"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"Ca","year":"2006","journal-title":"Semin Liver Dis"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Je","year":"2013","journal-title":"Gastroenterology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Aj","year":"2002","journal-title":"Lancet Lond Engl"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-6-3","article-title":"Primary sclerosing cholangitis \u2013 The arteriosclerosis of the bile duct","volume":"6","author":"Fickert","year":"2007","journal-title":"Lipids Health Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1206025\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T14:14:32Z","timestamp":1730384072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1206025\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,20]]},"references-count":139,"alternative-id":["10.3389\/fimmu.2023.1206025"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1206025","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,20]]},"article-number":"1206025"}}